Long covid: risk factors, outcomes, and future directions for research.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed.

1. Long COVID longitudinal symptoms burden clusters within a national community-based cohort.BMC infectious diseases · 2026
   Article
2. Barriers to Mobility in the ICU: Insights from Severe COVID-19 and Implications for Improving Patient Outcomes.Archives of rehabilitation research and clinical translation · 2025
   Article
3. Long COVID Longitudinal Symptoms Burden Clusters Within A National Community-Based Cohort.medRxiv : the preprint server for health sciences · 2025
   Article
4. Japanese nationwide survey to track the impact of long COVID over 3 years.Environmental health and preventive medicine · 2025
   Article
5. SARS-CoV-2 and the DNA damage response.The Journal of general virology · 2023
   Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as